The research, published in Nature Microbiology, has only been tested on mice thus far, but it offers a new pathway to fighting the aforementioned hard-to-treat infections. The polymers, called structurally nanoengineered antimicrobial peptide polymers or SNAPPs, attack the superbug bacteria’s cell membrane. SNAPPs don’t affect healthy cells as they are too large to enter them.
According to the CDC, around 2 million people become infected with bacteria that are resistant to antibiotics and at least 23,000 people die each year as a result of these infections. In September, all 193 United Nation member states agreed in a declaration to address the growing threat of antibiotic resistance — a historic occasion as it was only the fourth time the U.N. General Assembly had discussed a health issue.
While it’s still too early to be sure that the polymers would strike a significant blow to the antibiotic resistance problem, there is a cause for hope, according to the report.
More articles on healthcare quality:
Virginia Mason regains full Joint Commission accreditation
CMS awards $347M to healthcare organizations to support quality improvement efforts
CDC, dialysis organizations partner to reduce bloodstream infections
